Estimated covariance parameter and fixed coefficients for the authorship questionnaire, comparing the “other” to the “delay” response. by Junhui Kim (18575083)

Subjects:

Experimental design. by Felix L. Herr (21544362)

Experiment 5. by Jiehui Qian (294581)

“…<p>a) Two lines and two bars flickered at 4 Hz during the 30-s adaptation phase; only flickering bars were shown during the afterimage phase. b) Left: the olive bar indicates the mean illusory decrease of the lower bar length in Experiment 5, 3.16%. …”

A misleading tail: a long-term study of reptile responses to multiple disturbances undermined by a change in surveying techniques by Maldwyn Evans (13042281)

“…At about the midway point of our study (in 2011), we were forced to make a change in the way our data were collected. …”

Calcineurin acts as a Ca²⁺ sensor for metamodulation of LP I_h in 5nM DA. by Wulf-Dieter C. Krenz (693267)

“…Experiments were performed as described for <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0117965#pone.0117965.g005" target="_blank">Fig. 5</a> using the calcineurin inhibitor, FK506. …”

The boxplots present the mean cross-validated integrated Brier scores from the 1000 simulations for each of the sample sizes for the interaction simulations. by Justine B. Nasejje (14307679)

Pancreas-Specific Sirt1-Deficiency in Mice Compromises Beta-Cell Function without Development of Hyperglycemia by Andreia V. Pinho (749942)

“…This points to a unique compensatory mechanism. Given the reduction in PP, investigation of its role in the control of blood glucose is warranted.…”

Summary of the overall demographic and clinical characteristics of 43 pediatric oncology patients with 44 episodes of mucormycosis, and those of episodes in which Mucorales infecti... by Gabriela A. Marón (17941257)

Image no.5: A: One test paper in the original data; B: Recovering by 6D [RGB+HSV] file (<i>n</i> = 10); C: Dividing the paper into 384 rectangles for 2D spatial uniformness testing... by Shuting Liao (9524506)

UBKIs possess broad antiviral activity, are effective in primary cells, and impose a barrier against resistance development. by Markus Lesch (6475409)

“…The calculation of p-values revealed a significant decrease of log-transformed virus-titers in the regorafenib and sorafenib-treated groups relative to the DMSO control at the indicated time points: *: p-value ≤ 0.05. …”

<i>In vivo</i> specific delivery and biodistribution of LNP-Fluc mRNA. by Ying-Chou Chen (263436)

Subjects:

Evaluation of <i>in vitro</i> activity of LNP-siRNA on LX-2 cells stimulated by 2 ng/mL of TGF-β. by Ying-Chou Chen (263436)

Subjects:

Fig 7 - by Ying-Chou Chen (263436)

Subjects:

Cellular uptake properties of LNP-siRNA by LX-2 cells. by Ying-Chou Chen (263436)

Subjects:

Proposed mechanism of LNP-siTGFβRI action on schistosomiasis-induced liver fibrosis. by Ying-Chou Chen (263436)

Subjects:

Different inhibitors and their endocytic pathways inhibited. by Ying-Chou Chen (263436)

Subjects:

Raw data of the results in all figures. by Ying-Chou Chen (263436)

Subjects:

Characterization of LNP-siTGFβRI. by Ying-Chou Chen (263436)

Subjects:

Physicochemical parameters of LNP-RNAs used in the study. by Ying-Chou Chen (263436)

Subjects:

Boxplots showing the differences in miR-21-5p and miR-16-5p levels across increasing AKI severity based on Kidney Disease: Improving Global Outcomes (KDIGO) grades. by Tamar J. van der Aart (22184206)